CU6 — Clarity Pharmaceuticals Share News
0.000.00%
- AU$695.59m
- AU$517.34m
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial
Brief: Clarity Pharmaceuticals To Commence Phase III Trial Of 64 Cu-Sartate In NETS
Australia's Clarity Pharmaceuticals extends gains post Jefferies upgrade
Australia's Clarity Pharma rises; Jefferies upgrades to 'buy' after latest trial
Jefferies upgrades Australia's Clarity Pharma to 'buy' after latest trial
Brief: Clarity Signs Copper-67 Supply Agreement With Nusano
Australia's Clarity Pharmaceuticals rises on deal with US co
Brief: Clarity Pharmaceuticals Signs Copper-67 Supply Agreement With Nusano
Australian healthcare stocks drop on dismal earnings, regulatory hurdles
Australia's Clarity Pharmaceuticals plunges as full year loss widens
Brief: Clarity Pharmaceuticals Completes A$203 Million Institutional Placement At Issue Price A$4.20 Per Share
Australia's Clarity Pharmaceuticals jumps on premium placement
Australia's Clarity Pharmaceuticals rises on successful trial recruitment
Australian healthcare stocks gain as CSL advances to 1-1/2 month high
Australia's Clarity Pharmaceuticals rises on deal with SpectronRx
Brief: Clarity Pharmaceuticals Enters Commercial Manufacturing Agreement